Avricore Health Inc. Files July 2025 6-K Report
Ticker: AVCRF · Form: 6-K · Filed: Aug 8, 2025 · CIK: 1355736
| Field | Detail |
|---|---|
| Company | Avricore Health INC. (AVCRF) |
| Form Type | 6-K |
| Filed Date | Aug 8, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, foreign-private-issuer, corporate-update
TL;DR
AVRICORE HEALTH (AVRX) filed its July 6-K, standard foreign issuer report.
AI Summary
Avricore Health Inc. filed a Form 6-K on August 8, 2025, for the month of July 2025. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceuticals Inc., and ALDA Pharmaceuticals Corp., is headquartered in Vancouver, BC. This filing is a report of a foreign private issuer.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Avricore Health Inc.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Avricore Health Inc. (company) — Registrant
- Vanc Pharmaceuticals Inc. (company) — Former company name
- NUVA Pharmaceuticals Inc. (company) — Former company name
- ALDA Pharmaceuticals Corp. (company) — Former company name
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information required by Avricore Health Inc. as a foreign private issuer for the month of July 2025.
When was Avricore Health Inc. previously known by other names?
Avricore Health Inc. was formerly known as Vanc Pharmaceuticals Inc. (name change 20140911), NUVA Pharmaceuticals Inc. (name change 20140110), and ALDA Pharmaceuticals Corp. (name change 20060309).
What is Avricore Health Inc.'s principal executive office address?
Avricore Health Inc.'s principal executive office is located at 1120-789 West Pender St, Vancouver, BC, V6C 1H2.
Does Avricore Health Inc. file annual reports under Form 20-F or Form 40-F?
Avricore Health Inc. indicates it files annual reports under Form 20-F.
What is the SEC file number for Avricore Health Inc.?
The SEC file number for Avricore Health Inc. is 000-51848.
Filing Stats: 381 words · 2 min read · ~1 pages · Grade level 17.4 · Accepted 2025-08-07 20:02:53
Filing Documents
- form6-k.htm (6-K) — 18KB
- ex1.htm (EX-1) — 25KB
- ex1_001.jpg (GRAPHIC) — 14KB
- 0001641172-25-022639.txt ( ) — 64KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AVRICORE HEALTH INC. Date: August 07, 2025 By “Kiki Smith” Kiki Smith Chief Financial Officer SEC1815(04-09) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number